Table 13.
Sensitivity and specificity (summary of all reviewed studies)
| M/Ba | PTC/FA | FVPTC/ FA | FVPTC/FTC | FTC/FA | PTC/NTb | HCC/HCA | ||
|---|---|---|---|---|---|---|---|---|
| CK19 | Sensitivity | 80 % | 90 % | 74 % | 74 % | 28 % | 90 % | 51 % |
| Specificity | 78 % | 77 % | 77 % | 72 % | 77 % | 82 % | 57 % | |
| HBME1 | Sensitivity | 76 % | 88 % | 77 % | 77 % | 64 % | 88 % | 35 % |
| Specificity | 87 % | 73 % | 73 % | 36 % | 73 % | 93 % | 57 % | |
| GAL 3 | Sensitivity | 84 % | 93 % | 81 % | 81 % | 50 % | 93 % | 88 % |
| Specificity | 83 % | 78 % | 78 % | 50 % | 78 % | 86 % | 77 % | |
| CD56 | Sensitivity | 80 % | 86 % | 78 % | 78 % | 40 % | 86 % | 10 % |
| Specificity | 93 % | 83 % | 83 % | 60 % | 83 % | 54 % | 90 % |
aMalignant vs Benign; bPapillary thyroid carcinoma vs Non Tumor Tissue